Pfizer Inc (MIL:1PFE)
€ 24.625 -0.16 (-0.65%) Market Cap: 138.78 Bil Enterprise Value: 192.52 Bil PE Ratio: 34.89 PB Ratio: 1.59 GF Score: 64/100

Pfizer Inc Virtual Investor Day: Day 2 Transcript

Sep 15, 2020 / 02:00PM GMT
Charles E. Triano
Pfizer Inc. - SVP of IR

Welcome back, and thank you for joining us this morning for part 2 of Investor Day, where we will cover the remainder of our key R&D programs. Today, we'll hear from our immunology and inflammation, oncology and rare disease teams, and then we'll end with a segment on our COVID vaccine and antiviral programs.

As a reminder, presentations at today's session include forward-looking statements about, among other things, our anticipated future operating and financial performance, business plans and prospects and expectations for our product pipeline, in-line products and product candidates. By their nature, all statements about future events and expectations for our pipeline products are forward-looking. Each forward-looking statement contained in these presentations is subject to risks and uncertainties that could cause actual results to differ materially from those in such statements. Additional information regarding these factors appears in the slide entitled Forward-Looking Statements and Other Notices and under Risk Factors in our 10-K and 10-Qs.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot